MYC and chronic myelogenous leukemia, BCR-ABL1 positive: More intriguingly, the top four aberrantly expressed pathways in CML stem/progenitor cells including E2F targets, G2M checkpoint, DNA repair and MYC targets pathways (Fig. 1B) were remarkably downregulated (Fig. 4J).